-+ 0.00%
-+ 0.00%
-+ 0.00%

After Bojian's mid-term antidepressant trial failed, its stock price fell 10.4%

Zhitongcaijing·12/26/2025 14:41:07
Listen to the news
After Bojian's mid-term antidepressant trial failed, its stock price fell 10.4%